Drug intelligence / Profile preview

potassium chloride + magnesium chloride + sodium gluconate + sodium chloride + sodium acetate

Development stage
Unknown
Lead developer
Baxter Healthcare Corporation
Modality
Small Molecules
Administration
Intravenous
01

Overview

Potassium chloride + magnesium chloride + sodium gluconate + sodium chloride + sodium acetate is a sterile, nonpyrogenic, isotonic intravenous electrolyte replacement solution marketed as Plasma-Lyte A. It is a **small-molecule electrolyte combination product** developed and manufactured by Baxter for fluid and electrolyte replenishment and for use as an alkalinizing agent. The solution provides water plus physiologic ions including sodium, potassium, magnesium, chloride, acetate, and gluconate; acetate is metabolized to bicarbonate, supporting correction of metabolic acidosis, while the balanced electrolyte composition helps restore extracellular fluid volume and electrolyte homeostasis in settings such as dehydration and electrolyte imbalance. It is supplied as an intravenous solution and corresponds specifically to the pH 7.4 Multiple Electrolytes Injection, Type 1 formulation rather than other related balanced crystalloid or irrigation products.

Brand names
Plasma-Lyte A
Other names
Multiple Electrolytes Injection Type 1Multiple Electrolytes Injection Type 1 USP pH 7.4PLASMA-LYTE A Injection pH 7.4

Beyond the preview

Go deeper on potassium chloride + magnesium chloride + sodium gluconate + sodium chloride + sodium acetate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on potassium chloride + magnesium chloride + sodium gluconate + sodium chloride + sodium acetate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call